COMMUNIQUÉS West-GlobeNewswire

Alphatec Announces Participation At Canaccord and Cowen Investor Conferences in March

08/03/2019 - 15:05

CARLSBAD, Calif., March 08, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), today announced it will present at two healthcare investor conferences as follows: ATEC will present [...]

Y-mAbs Therapeutics To Present At Cowen’s 39th Annual Health Care Conference

08/03/2019 - 15:03

NEW YORK, March 08, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy

08/03/2019 - 15:00

Industry Veteran John P. Sentman to Lead Strategic Sales and Partnering MIRAMAR, FL, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Olaregen Therapeutix, a subsidiary of Generex Biotechnology Corporation ( www. [...]

Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.

08/03/2019 - 14:30

Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group; William Hilson Appointed Chief Commercial Officer TORONTO, March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc [...]

Kaleido Biosciences to Highlight its Platform to Identify and Evaluate Microbiome Metabolic Therapies to Reduce Gut Ammonia Production in Presentation at Keystone Symposia on Microbiome

08/03/2019 - 14:30

LEXINGTON, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the [...]

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results

08/03/2019 - 14:12

BOSTON, March 08, 2019 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

Tauriga Sciences Inc. to Produce Additional Tauri-Gum™ Inventory Due to Stronger than Expected Indications of Demand

08/03/2019 - 14:07

New York, NY, March 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]

Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2019

08/03/2019 - 14:00

REHOVOT, Israel and BRIDGEWATER, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]

Selecta Biosciences to Report Fourth Quarter and Year End 2018 Financial Results and Provide Corporate Update

08/03/2019 - 14:00

WATERTOWN, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on [...]

Rexahn Pharmaceuticals Reports 2018 Financial Results

08/03/2019 - 14:00

ROCKVILLE, Md., March 08, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers [...]

electroCore Appointments Multiple Industry Veterans to Key Management Positions

08/03/2019 - 14:00

Dr. Tony Fiorino to serve as Chief Medical Officer and Brian Posner as Chief Financial Officer BASKING RIDGE, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic [...]

Allogene Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

08/03/2019 - 14:00

Phase 1 ALLO-501 Clinical Trial On-Track for Initiation in 1H 2019 Trial Includes Dose Escalation to Determine the Optimal Dose of ALLO-501 and Use of ALLO-647 for Lymphodepletion in Patients with Relapsed/Refractory [...]

AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena® (hydroxyprogesterone caproate injection)

08/03/2019 - 14:00

WALTHAM, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today topline results from PROLONG (Progestin’s Role in Optimizing Neonatal Gestation), a randomized, double-blinded [...]

Blissco Ships Initial Order to BC Liquor Distribution Branch

08/03/2019 - 14:00

Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, March 08, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]

BioSig Technologies to Present at the LD Micro Virtual Conference

08/03/2019 - 13:52

Santa Monica, CA, March 08, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed [...]

Strongbridge Biopharma plc Announces New Employment Inducement Awards

08/03/2019 - 13:30

DUBLIN, Ireland and TREVOSE, Pa., March 08, 2019 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of [...]

TG Therapeutics Announces Positive Data Safety Monitoring Board Reviews of UNITY-CLL and UNITY-NHL Clinical Trials

08/03/2019 - 13:30

UNITY-CLL DSMB conducted a pre-planned futility analysis of progression-free survival, and determined that the study was not futile and should continue as planned No safety concerns identified by the independent DSMBs [...]

New Trogarzo® Data Presented at Conference on Retroviruses and Opportunistic Infections demonstrates Sustained Viral Suppression at Week 96

08/03/2019 - 13:29

MONTREAL, March 08, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that new data, presented today at the 26 th annual Conference on Retroviruses and Opportunistic [...]

De nouvelles données sur Trogarzo(MD), présentées lors de la Conference on Retroviruses and Opportunistic Infections, démontrent une suppression virale continue à la 96e semaine de traitement

08/03/2019 - 13:29

MONTRÉAL, 08 mars 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer que de nouvelles données de 96 semaines, présentées lors de la 26 ième édition de la Conference on [...]